KAN — Kancera AB Income Statement
0.000.00%
- SEK190.26m
- SEK159.25m
Annual income statement for Kancera AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | Interim Report | ARS | ARS | ARS |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.22 | 0.09 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 3.12 | 0.063 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 38.9 | 39.5 | 45.3 | 51.9 | 65 |
Operating Profit | -35.7 | -39.5 | -45.3 | -51.9 | -65 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -36.1 | -40.5 | -45.7 | -52.5 | -64.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -36.1 | -40.5 | -45.7 | -52.5 | -64.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -36.1 | -40.5 | -45.7 | -52.5 | -64.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -36.1 | -40.5 | -45.7 | -52.5 | -64.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.48 | -0.933 | -0.706 | -0.887 | -0.765 |
Dividends per Share |